Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CNMD | Common Stock | Options Exercise | $0 | +302 | +9.24% | $0.00 | 3.57K | May 31, 2024 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CNMD | Rsus (restricted Stock Units) | Options Exercise | $0 | -302 | -100% | $0.00* | 0 | May 31, 2024 | Common Stock | 302 | $0.00 | Direct | F1 |
transaction | CNMD | Options To Purchase Common Stock | Award | $0 | +5.5K | $0.00 | 5.5K | Jun 3, 2024 | Common Stock | 5.5K | $77.18 | Direct | F2 | |
transaction | CNMD | Rsus (restricted Stock Units) | Award | $0 | +479 | $0.00 | 479 | Jun 3, 2024 | Common Stock | 479 | $0.00 | Direct | F1 |
Id | Content |
---|---|
F1 | Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. |
F2 | The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. |